Tumor RIPK1 signaling mediates intrinsic and extrinsic mechanisms of resistance to immune checkpoint blockade therapy

被引：0
|
作者：
Cucolo, Lisa [1 ,2 ]
Qiu, Jingya [1 ,2 ]
Klapholz, Max [1 ,2 ]
Shi, Junwei [3 ]
Gilliland, Gary [4 ]
Jordan, Martha [5 ]
Minn, Andy [1 ,2 ,6 ]
机构：
[1] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA USA
[3] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA USA
[4] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA
[5] Univ Penn, Perelman Sch Med Pathol & Lab Med, Philadelphia, PA 19104 USA
[6] Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA
来源：
JOURNAL OF IMMUNOLOGY | 2020年 / 204卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
241.29
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Mechanisms of Resistance to PD-1 Checkpoint Blockade
    Moser, Justin C.
    Hu-Lieskovan, Siwen
    DRUGS, 2020, 80 (05) : 459 - 465
  • [42] Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade
    Chen, Pei-Ling
    Roh, Whijae
    Reuben, Alexandre
    Cooper, Zachary A.
    Spencer, Christine N.
    Prieto, Peter A.
    Miller, John P.
    Bassett, Roland L.
    Gopalakrishnan, Vancheswaran
    Wani, Khalida
    De Macedo, Mariana Petaccia
    Austin-Breneman, Jacob L.
    Jiang, Hong
    Chang, Qing
    Reddy, Sangeetha M.
    Chen, Wei-Shen
    Tetzlaff, Michael T.
    Broaddus, Russell J.
    Davies, Michael A.
    Gershenwald, Jeffrey E.
    Haydu, Lauren
    Lazar, Alexander J.
    Patel, Sapna P.
    Hwu, Patrick
    Hwu, Wen-Jen
    Diab, Adi
    Glitza, Isabella C.
    Woodman, Scott E.
    Vence, Luis M.
    Wistuba, Ignacio I.
    Amaria, Rodabe N.
    Kwong, Lawrence N.
    Prieto, Victor
    Davis, R. Eric
    Ma, Wencai
    Overwijk, Willem W.
    Sharpe, Arlene H.
    Hu, Jianhua
    Futreal, P. Andrew
    Blando, Jorge
    Sharma, Padmanee
    Allison, James P.
    Chin, Lynda
    Wargo, Jennifer A.
    CANCER DISCOVERY, 2016, 6 (08) : 827 - 837
  • [43] Selective inhibition of TGFβ1 activation overcomes primary resistance to checkpoint blockade therapy by altering tumor immune landscape
    Martin, Constance J.
    Datta, Abhishek
    Littlefield, Christopher
    Kalra, Ashish
    Chapron, Christopher
    Wawersik, Stefan
    Dagbay, Kevin B.
    Brueckner, Christopher T.
    Nikiforov, Anastasia
    Danehy, Francis T., Jr.
    Streich, Frederick C., Jr.
    Boston, Christopher
    Simpson, Allison
    Jackson, Justin W.
    Lin, Susan
    Danek, Nicole
    Faucette, Ryan R.
    Raman, Pichai
    Capili, Allan D.
    Buckler, Alan
    Carven, Gregory J.
    Schurpf, Thomas
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (536)
  • [44] Clonal tracing reveals different mechanisms of resistance to immune checkpoint blockade
    Gu, Shengqing
    Hu, Xihao
    Wang, Xiaoqing
    Jiang, Peng
    Li, Ziyi
    Traugh, Nicole
    Bu, Xia
    Xing, Xiaofang
    Freeman, Gordon J.
    Brown, Myles
    Liu, Xiaole S.
    CANCER RESEARCH, 2019, 79 (13)
  • [45] Tumor intrinsic CDC42BPB confers resistance to anti-PD-1 immune checkpoint blockade in breast cancer
    Deshpande, Ravindra Pramod
    Wu, Kerui
    Wu, Shih-Ying
    Tyagi, Abhishek
    Hunting, John
    Ruiz, Jimmy
    Li, Wencheng
    Watabe, Kounosuke
    CANCER RESEARCH, 2024, 84 (06)
  • [46] Epigenetic Modulation of the Tumor Immune Microenvironment to Potentiate Immune Checkpoint Blockade Therapy
    Menzel, Johannes
    Black, Joshua C.
    CANCER DISCOVERY, 2020, 10 (02) : 179 - 181
  • [47] Constitutive and acquired mechanisms of resistance to immune checkpoint blockade in human cancer
    Bellone, Matteo
    Elia, Angela Rita
    CYTOKINE & GROWTH FACTOR REVIEWS, 2017, 36 : 17 - 24
  • [48] Mechanisms underlying response and resistance to immune checkpoint blockade in cancer immunotherapy
    Lee, Junghwa
    Kim, Eui Ho
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [49] Targeting mesenchymal tumor cell-intrinsic factors sensitizes refractory tumors to immune checkpoint blockade therapy
    Bakhle, Kimaya M.
    Sams, Caitie H.
    Dongre, Anushka
    CANCER RESEARCH, 2024, 84 (06)
  • [50] Innate immune signaling through differential RIPK1 expression promote tumor progression in head and neck squamous cell carcinoma
    McCormick, Kevin D.
    Ghosh, Arundhati
    Trivedi, Sumita
    Wang, Lin
    Coyne, Carolyn B.
    Ferris, Robert L.
    Sarkar, Saumendra N.
    CARCINOGENESIS, 2016, 37 (05) : 522 - 529
12345